Nanopore Sequencing Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 431.74 Million
CAGR (2026-2031)	10.61%
Fastest Growing Segment	Consumables
Largest Market	North America
Market Size (2031)	USD 790.66 Million

Market Overview

The Global Nanopore Sequencing Market will grow from USD 431.74 Million in 2025 to USD 790.66 Million by 2031 at a 10.61% CAGR. Nanopore sequencing is a genomic analysis technology that determines nucleotide sequences by measuring changes in electrical current as nucleic acid molecules traverse a protein or solid-state nanopore. The market’s expansion is primarily driven by the increasing necessity for long-read sequencing to resolve complex structural variants and the rising demand for portable, real-time pathogen surveillance in decentralized settings. According to the World Health Organization, in 2024, the International Pathogen Surveillance Network awarded nearly two million US dollars in grants to projects enhancing global genomic analysis capacities, reflecting the critical investment in these diagnostic infrastructures.

However, a significant challenge impeding broader market expansion is the inherent complexity of data analysis required to address raw read error rates, which remain higher than those of established short-read platforms. This technical limitation necessitates substantial computational resources for accurate interpretation, thereby creating a barrier to entry for smaller laboratories lacking advanced bioinformatics infrastructure.

Key Market Drivers

Expanding applications in clinical diagnostics and precision medicine serve as a primary catalyst for the Global Nanopore Sequencing Market. As the technology matures, it is increasingly transitioning from research laboratories to regulated healthcare environments, where it is utilized for rapid pathogen characterization and human genetic analysis. This shift is evidenced by the accelerated adoption of nanopore-based tests in hospital settings, which offer faster turnaround times compared to traditional methods. According to FirstWord HealthTech, September 2025, in the 'Oxford Nanopore Interim results for the six months ended 30 June 2025' report, revenue within the Clinical segment increased by 52.9% compared to the prior year, underscoring the rapid commercial traction of these diagnostic solutions in real-world medical frameworks.

Reduced capital barriers and cost-effective scalability further propel market growth by democratizing access to high-throughput genomic data. The availability of scalable sequencing platforms allows institutions to perform large-scale population studies and complex genome assemblies without the prohibitive infrastructure costs associated with legacy systems. This efficiency is driving substantial hardware adoption; according to the Financial Times, March 2025, in the 'Annual results for the year ended 31 December 2024' article, revenue from the high-output PromethION product range grew by 55.8% as customer utilization rates surged. This operational scalability is supported by a robust scientific foundation, validated by the broader research community. According to IP Group, in 2025, approximately 3,000 peer-reviewed research papers were published by users of this technology during the previous year, highlighting the extensive validation supporting its diverse market applications.

Download Free Sample Report

Key Market Challenges

The Global Nanopore Sequencing Market faces a significant impediment due to the intricate data analysis required to mitigate high raw read error rates. Nanopore platforms generate complex electrical signal data that demand extensive computational power and specialized bioinformatics workflows for accurate interpretation. This technical requirement imposes a heavy infrastructure burden, effectively excluding smaller research facilities and decentralized diagnostic centers that lack the necessary processing capabilities or financial resources to manage such demanding workloads.

This computational bottleneck acts as a critical barrier to entry for potential users in resource-limited settings. The difficulty of managing complex biological data is a recognized hurdle across the wider industry. According to the Pistoia Alliance, in 2024, 54% of life science experts identified unstructured data as a major barrier to utilizing experimental outputs effectively. This statistic highlights the operational difficulties laboratories face when dealing with raw, non-standardized data streams similar to those produced by nanopore devices. Consequently, organizations without advanced informatics support are deterred from adopting these platforms, thereby slowing the technology’s integration into routine clinical and surveillance applications where rapid and simple data processing is essential.

Key Market Trends

The Integration of Artificial Intelligence for Real-time Data Analytics is fundamentally reshaping the Global Nanopore Sequencing Market by addressing the critical bottleneck of data complexity. Advanced machine learning algorithms are increasingly embedded within sequencing workflows to enable basecalling and variant detection with unprecedented speed, effectively mitigating the high raw read error rates that historically challenged the technology. This technological synergy allows for immediate, edge-based interpretation of complex genomic signals, reducing the reliance on heavy centralized computational infrastructure. The scale of this technological shift is reflected in the surging investment into the underlying computing power required for such genomic applications; according to Sahm Capital, January 2025, in the 'Nvidia Eyes $1 Billion In Healthcare AI Revenue' article, analysts projected that the healthcare sector would contribute one billion US dollars in annual recurring revenue to the leading GPU manufacturer by 2026, driven largely by the demand for AI-driven genomic and drug discovery platforms.

Simultaneously, the market is witnessing a Convergence with Multi-omics and Proteomics Research Applications, moving beyond isolationist DNA analysis to comprehensive biological profiling. This trend is characterized by the expansion of nanopore sensing capabilities to directly analyze RNA molecules and protein structures, thereby attracting substantial interest from the pharmaceutical sector for drug development and quality control workflows. This shift towards industrial application is evidenced by the growing uptake of sequencing platforms in commercial research settings. According to Oxford Nanopore Technologies, September 2025, in the 'Interim results for the six months ended 30 June 2025' report, revenue from the BioPharma customer segment grew by 18.5% compared to the same period in the previous year, highlighting the increasing reliance on multi-omic nanopore data for regulated therapeutic development and manufacturing processes.

Segmental Insights

The Consumables segment is identified as the fastest growing category within the Global Nanopore Sequencing Market due to the highly recurring nature of product demand. Unlike instruments which represent one-time capital expenditures, consumables such as flow cells, reagents, and library preparation kits are essential for every individual sequencing run. The continuous expansion of genomic research and the increasing adoption of sequencing for infectious disease monitoring necessitate frequent replenishment of these materials. Consequently, as the global installed base of sequencing platforms widens, the cumulative volume of consumable orders accelerates, thereby driving the segment's rapid expansion.

Regional Insights

North America maintains a dominant position in the global nanopore sequencing market, primarily due to substantial investments in genomic research and a well-established biotechnology sector. The region benefits from extensive funding for precision medicine and large-scale population health initiatives, notably supported by the National Institutes of Health. Additionally, the concentrated presence of leading pharmaceutical companies and academic research centers accelerates the adoption of sequencing technologies for clinical diagnostics and drug discovery. This robust infrastructure creates a favorable environment for the continuous integration of genomic analysis into healthcare systems across the region.

Recent Developments

In May 2025, Oxford Nanopore Technologies unveiled significant technology and pipeline updates during its annual London Calling conference. The company announced the expansion of its Q-Line product range, including the PromethION Q, which was scheduled for launch in 2026 to support high-throughput human sequencing applications in regulated environments. Additionally, the company highlighted progress on a new voltage-controlled application-specific integrated circuit (ASIC) designed to enhance sensing capabilities. These updates underscored the company’s long-term roadmap to deliver increasingly rich, high-performance multi-omic data and to advance its solutions for clinical and industrial markets.
In April 2025, Oxford Nanopore Technologies expanded its Compatible Products Programme by welcoming a new cohort of industry-leading partners, including 10x Genomics, Agilent Technologies, and Thermo Fisher Scientific. This initiative, originally established to support third-party content development, certified that the partners' products integrated seamlessly with Oxford Nanopore’s molecular sensing platform. The approved products, ranging from single-cell analysis tools to automated sample preparation solutions, underwent rigorous validation to ensure optimal performance. This expansion aimed to provide researchers with flexible, end-to-end multi-omic workflows, thereby broadening the accessibility and application of long-read sequencing technologies in diverse scientific settings.
In September 2024, a research team from the University of Washington, in collaboration with Oxford Nanopore Technologies, published a breakthrough study in Nature demonstrating a new method for protein sequencing. The study detailed a "multi-pass" technique that successfully read long, intact protein strands at single-molecule resolution using a commercial nanopore sensor array. By utilizing a specific unfoldase enzyme to ratchet proteins through the nanopore, the researchers achieved high accuracy in identifying amino acids and detecting post-translational modifications. This development marked a significant step forward in proteomics, expanding the potential of nanopore sensing technology beyond DNA and RNA sequencing to complex protein analysis.
In May 2024, Oxford Nanopore Technologies announced a strategic collaboration with Twist Bioscience to launch a Pharmacogenomics Beta Programme, aimed at advancing personalized medicine. This partnership integrated Twist Bioscience’s next-generation sequencing target enrichment technology with Oxford Nanopore’s sequencing platform to provide a streamlined workflow for pharmacogenomic analysis. The joint solution was designed to deliver unambiguous genetic results in a single end-to-end workflow, reducing the need for time-consuming follow-up tests. This initiative allowed researchers to expand the diversity of genetic variants evaluated, supporting the development of customized therapies based on individual genetic profiles.

Key Market Players

Oxford Nanopore Technologies plc
Illumina, Inc
Agilent Technologies, Inc
Roche Sequencing Solutions, Inc.
10X Genomics Inc
Nabsys, Inc
Laboratory Corporation of America Holdings
Quantapore Inc
INanoBio Inc
Electronic BioSciences, Inc.

By Product	By Nucleotide Sequenced	By Type	By Type of Nanopore	By Application	By End User	By Region
Consumables Instruments	DNA RNA	Direct Current Sequencing Synthetic DNA and Horizontal Tunnelling Current Sequencing Optical Reading Techniques Sequencing Exonuclease Sequencing	Solid State Biological Hybrid	Human Genetics Clinical Research Plant Research Microbiology Animal Research	Biotechnology Companies Clinical Laboratories Academic & Research Institutes	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Nanopore Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nanopore Sequencing Market, By Product:

Consumables
Instruments

Nanopore Sequencing Market, By Nucleotide Sequenced:

Nanopore Sequencing Market, By Type:

Direct Current Sequencing
Synthetic DNA and Horizontal Tunnelling Current Sequencing
Optical Reading Techniques Sequencing
Exonuclease Sequencing

Nanopore Sequencing Market, By Type of Nanopore:

Solid State
Biological
Hybrid

Nanopore Sequencing Market, By Application:

Human Genetics
Clinical Research
Plant Research
Microbiology
Animal Research

Nanopore Sequencing Market, By End User:

Biotechnology Companies
Clinical Laboratories
Academic & Research Institutes

Nanopore Sequencing Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nanopore Sequencing Market.

Available Customizations:

Global Nanopore Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Nanopore Sequencing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nanopore Sequencing Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Consumables, Instruments)

5.2.2. By Nucleotide Sequenced (DNA, RNA)

5.2.3. By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing)

5.2.4. By Type of Nanopore (Solid State, Biological, Hybrid)

5.2.5. By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research)

5.2.6. By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes)

5.2.7. By Region

5.2.8. By Company (2025)

5.3. Market Map

6. North America Nanopore Sequencing Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product

6.2.2. By Nucleotide Sequenced

6.2.3. By Type

6.2.4. By Type of Nanopore

6.2.5. By Application

6.2.6. By End User

6.2.7. By Country

6.3. North America: Country Analysis

6.3.1. United States Nanopore Sequencing Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By Nucleotide Sequenced

6.3.1.2.3. By Type

6.3.1.2.4. By Type of Nanopore

6.3.1.2.5. By Application

6.3.1.2.6. By End User

6.3.2. Canada Nanopore Sequencing Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By Nucleotide Sequenced

6.3.2.2.3. By Type

6.3.2.2.4. By Type of Nanopore

6.3.2.2.5. By Application

6.3.2.2.6. By End User

6.3.3. Mexico Nanopore Sequencing Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By Nucleotide Sequenced

6.3.3.2.3. By Type

6.3.3.2.4. By Type of Nanopore

6.3.3.2.5. By Application

6.3.3.2.6. By End User

7. Europe Nanopore Sequencing Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product

7.2.2. By Nucleotide Sequenced

7.2.3. By Type

7.2.4. By Type of Nanopore

7.2.5. By Application

7.2.6. By End User

7.2.7. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Nanopore Sequencing Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By Nucleotide Sequenced

7.3.1.2.3. By Type

7.3.1.2.4. By Type of Nanopore

7.3.1.2.5. By Application

7.3.1.2.6. By End User

7.3.2. France Nanopore Sequencing Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By Nucleotide Sequenced

7.3.2.2.3. By Type

7.3.2.2.4. By Type of Nanopore

7.3.2.2.5. By Application

7.3.2.2.6. By End User

7.3.3. United Kingdom Nanopore Sequencing Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By Nucleotide Sequenced

7.3.3.2.3. By Type

7.3.3.2.4. By Type of Nanopore

7.3.3.2.5. By Application

7.3.3.2.6. By End User

7.3.4. Italy Nanopore Sequencing Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By Nucleotide Sequenced

7.3.4.2.3. By Type

7.3.4.2.4. By Type of Nanopore

7.3.4.2.5. By Application

7.3.4.2.6. By End User

7.3.5. Spain Nanopore Sequencing Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By Nucleotide Sequenced

7.3.5.2.3. By Type

7.3.5.2.4. By Type of Nanopore

7.3.5.2.5. By Application

7.3.5.2.6. By End User

8. Asia Pacific Nanopore Sequencing Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product

8.2.2. By Nucleotide Sequenced

8.2.3. By Type

8.2.4. By Type of Nanopore

8.2.5. By Application

8.2.6. By End User

8.2.7. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Nanopore Sequencing Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By Nucleotide Sequenced

8.3.1.2.3. By Type

8.3.1.2.4. By Type of Nanopore

8.3.1.2.5. By Application

8.3.1.2.6. By End User

8.3.2. India Nanopore Sequencing Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By Nucleotide Sequenced

8.3.2.2.3. By Type

8.3.2.2.4. By Type of Nanopore

8.3.2.2.5. By Application

8.3.2.2.6. By End User

8.3.3. Japan Nanopore Sequencing Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By Nucleotide Sequenced

8.3.3.2.3. By Type

8.3.3.2.4. By Type of Nanopore

8.3.3.2.5. By Application

8.3.3.2.6. By End User

8.3.4. South Korea Nanopore Sequencing Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By Nucleotide Sequenced

8.3.4.2.3. By Type

8.3.4.2.4. By Type of Nanopore

8.3.4.2.5. By Application

8.3.4.2.6. By End User

8.3.5. Australia Nanopore Sequencing Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By Nucleotide Sequenced

8.3.5.2.3. By Type

8.3.5.2.4. By Type of Nanopore

8.3.5.2.5. By Application

8.3.5.2.6. By End User

9. Middle East & Africa Nanopore Sequencing Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product

9.2.2. By Nucleotide Sequenced

9.2.3. By Type

9.2.4. By Type of Nanopore

9.2.5. By Application

9.2.6. By End User

9.2.7. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Nanopore Sequencing Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By Nucleotide Sequenced

9.3.1.2.3. By Type

9.3.1.2.4. By Type of Nanopore

9.3.1.2.5. By Application

9.3.1.2.6. By End User

9.3.2. UAE Nanopore Sequencing Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By Nucleotide Sequenced

9.3.2.2.3. By Type

9.3.2.2.4. By Type of Nanopore

9.3.2.2.5. By Application

9.3.2.2.6. By End User

9.3.3. South Africa Nanopore Sequencing Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By Nucleotide Sequenced

9.3.3.2.3. By Type

9.3.3.2.4. By Type of Nanopore

9.3.3.2.5. By Application

9.3.3.2.6. By End User

10. South America Nanopore Sequencing Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product

10.2.2. By Nucleotide Sequenced

10.2.3. By Type

10.2.4. By Type of Nanopore

10.2.5. By Application

10.2.6. By End User

10.2.7. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Nanopore Sequencing Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By Nucleotide Sequenced

10.3.1.2.3. By Type

10.3.1.2.4. By Type of Nanopore

10.3.1.2.5. By Application

10.3.1.2.6. By End User

10.3.2. Colombia Nanopore Sequencing Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By Nucleotide Sequenced

10.3.2.2.3. By Type

10.3.2.2.4. By Type of Nanopore

10.3.2.2.5. By Application

10.3.2.2.6. By End User

10.3.3. Argentina Nanopore Sequencing Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By Nucleotide Sequenced

10.3.3.2.3. By Type

10.3.3.2.4. By Type of Nanopore

10.3.3.2.5. By Application

10.3.3.2.6. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Nanopore Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Oxford Nanopore Technologies plc

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Illumina, Inc

15.3. Agilent Technologies, Inc

15.4. Roche Sequencing Solutions, Inc.

15.5. 10X Genomics Inc

15.6. Nabsys, Inc

15.7. Laboratory Corporation of America Holdings

15.8. Quantapore Inc

15.9. INanoBio Inc

15.10. Electronic BioSciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Figure 1:	Global Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 2:	Global Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 3:	Global Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 4:	Global Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 5:	Global Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 6:	Global Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 7:	Global Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 8:	Global Nanopore Sequencing Market Share, By Region, By Value, 2019-2029F
Figure 9:	Global Nanopore Sequencing Market Share, By Company, By Value, 2023
Figure 10:	Global Nanopore Sequencing Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2023
Figure 11:	Global Nanopore Sequencing Market Map, By Nucleotide Sequenced, Market Size (USD Million) & Growth Rate (%), 2023
Figure 12:	Global Nanopore Sequencing Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2023
Figure 13:	Global Nanopore Sequencing Market Map, By Type of Nanopore, Market Size (USD Million) & Growth Rate (%), 2023
Figure 14:	Global Nanopore Sequencing Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2023
Figure 15:	Global Nanopore Sequencing Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2023
Figure 16:	Global Nanopore Sequencing Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2023
Figure 17	North America Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 18:	North America Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 19:	North America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 20:	North America Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 21:	North America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 22:	North America Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 23:	North America Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 24:	North America Nanopore Sequencing Market Share, By Country, By Value, 2019-2029F
Figure 25:	United States Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 26:	United States Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 27:	United States Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 28:	United States Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 29:	United States Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 30:	United States Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 31:	United States Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 32:	Canada Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 33:	Canada Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 34:	Canada Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 35:	Canada Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 36:	Canada Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 37:	Canada Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 38:	Canada Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 39:	Mexico Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 40:	Mexico Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 41:	Mexico Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 42:	Mexico Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 43:	Mexico Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 44:	Mexico Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 45:	Mexico Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 46:	Europe Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 47:	Europe Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 48:	Europe Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 49:	Europe Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 50:	Europe Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 51:	Europe Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 52:	Europe Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 53:	Europe Nanopore Sequencing Market Share, By Country, By Value, 2019-2029F
Figure 54:	United Kingdom Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 55:	United Kingdom Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 56:	United Kingdom Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 57:	United Kingdom Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 58:	United Kingdom Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 59:	United Kingdom Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 60:	United Kingdom Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 61:	Germany Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 62:	Germany Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 63:	Germany Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 64:	Germany Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 65:	Germany Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 66:	Germany Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 67:	Germany Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 68:	France Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 69:	France Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 70:	France Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 71:	France Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 72:	France Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 73:	France Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 74:	France Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 75:	Spain Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 76:	Spain Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 77:	Spain Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 78:	Spain Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 79:	Spain Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 80:	Spain Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 81:	Spain Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 82:	Italy Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 83:	Italy Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 84:	Italy Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 85:	Italy Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 86:	Italy Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 87:	Italy Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 88:	Italy Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 89:	Asia Pacific Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 90:	Asia Pacific Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 91:	Asia Pacific Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 92:	Asia Pacific Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 93:	Asia Pacific Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 94:	Asia Pacific Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 95:	Asia Pacific Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 96:	Asia Pacific Nanopore Sequencing Market Share, By Country, By Value, 2019-2029F
Figure 97:	China Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 98:	China Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 99:	China Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 100:	China Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 101:	China Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 102:	China Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 103:	China Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 104:	Japan Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 105:	Japan Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 106:	Japan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 107:	Japan Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 108:	Japan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 109:	Japan Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 110:	Japan Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 111:	India Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 112:	India Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 113:	India Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 114:	India Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 115:	India Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 116:	India Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 117:	India Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 118:	Australia Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 119:	Australia Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 120:	Australia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 121:	Australia Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 122:	Australia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 123:	Australia Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 124:	Australia Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 125:	South Korea Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 126:	South Korea Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 127:	South Korea Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 128:	South Korea Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 129:	South Korea Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 130:	South Korea Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 131:	South Korea Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 132:	Taiwan Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029FF
Figure 133:	Taiwan Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 134:	Taiwan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 135:	Taiwan Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 136:	Taiwan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 137:	Taiwan Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 138:	Taiwan Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 139:	Singapore Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 140:	Singapore Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 141:	Singapore Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 142:	Singapore Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 143:	Singapore Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 144:	Singapore Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 145:	Singapore Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 146:	South America Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 147:	South America Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 148:	South America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 149:	South America Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 150:	South America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 151:	South America Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 152:	South America Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 153:	South America Nanopore Sequencing Market Share, By Country, By Value, 2019-2029F
Figure 154:	Brazil Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 155:	Brazil Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 156:	Brazil Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 157:	Brazil Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 158:	Brazil Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 159:	Brazil Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 160:	Brazil Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 161:	Argentina Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 162:	Argentina Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 163:	Argentina Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 164:	Argentina Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 165:	Argentina Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 166:	Argentina Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 167:	Argentina Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 168:	Colombia Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 169:	Colombia Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 170:	Colombia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 171:	Colombia Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 172:	Colombia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 173:	Colombia Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 174:	Colombia Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 175:	Middle East & Africa Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 176:	Middle East & Africa Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 177:	Middle East & Africa Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 178:	Middle East & Africa Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 179:	Middle East & Africa Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 180:	Middle East & Africa Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 181:	Middle East & Africa Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 182:	Middle East & Africa Nanopore Sequencing Market Share, By Country, By Value, 2019-2029F
Figure 183:	UAE Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 184:	UAE Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 185:	UAE Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 186:	UAE Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 187:	UAE Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 188:	UAE Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 189:	UAE Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 190:	Saudi Arabia Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 191:	Saudi Arabia Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 192:	Saudi Arabia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 193:	Saudi Arabia Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 194:	Saudi Arabia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 195:	Saudi Arabia Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 196:	Saudi Arabia Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F
Figure 197:	South Africa Nanopore Sequencing Market Size, By Value (USD Million), 2019-2029F
Figure 198:	South Africa Nanopore Sequencing Market Share, By Product, By Value, 2019-2029F
Figure 199:	South Africa Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2019-2029F
Figure 200:	South Africa Nanopore Sequencing Market Share, By Type, By Value, 2019-2029F
Figure 201:	South Africa Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2019-2029F
Figure 202:	South Africa Nanopore Sequencing Market Share, By Application, By Value, 2019-2029F
Figure 203:	South Africa Nanopore Sequencing Market Share, By End User, By Value, 2019-2029F

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Nanopore Sequencing Market in 2025?

Which is the dominating region in the Global Nanopore Sequencing Market?

Which is the fastest growing segment in the Global Nanopore Sequencing Market?

What is the expected growth rate of the Global Nanopore Sequencing Market?